These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23163265)

  • 1. X-linked juvenile retinoschisis in females and response to carbonic anhydrase inhibitors: case report and review of the literature.
    Ali S; Seth R
    Semin Ophthalmol; 2013 Jan; 28(1):50-4. PubMed ID: 23163265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combination of topical and systemic carbonic anhydrase in the treatment of chromosome X-linked retinoschisis.
    Rocha Cabrera P; Pareja Ríos AC; Cordovés Dorta L; Mantolán Sarmiento C; Serrano García MA
    Arch Soc Esp Oftalmol; 2014 Aug; 89(8):320-3. PubMed ID: 24269421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of adult-onset acute macular retinoschisis in enhanced s-cone syndrome with oral acetazolamide.
    Iannaccone A; Fung KH; Eyestone ME; Stone EM
    Am J Ophthalmol; 2009 Feb; 147(2):307-312.e2. PubMed ID: 18835469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid resolution of retinoschisis with acetazolamide.
    Zhang L; Reyes R; Lee W; Chen CL; Chan L; Sujirakul T; Chang S; Tsang SH
    Doc Ophthalmol; 2015 Aug; 131(1):63-70. PubMed ID: 25796216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetazolamide in the treatment of X-linked retinoschisis maculopathy.
    Ghajarnia M; Gorin MB
    Arch Ophthalmol; 2007 Apr; 125(4):571-3. PubMed ID: 17420384
    [No Abstract]   [Full Text] [Related]  

  • 6. Carbonic anhydrase inhibitors in patients with X-linked retinoschisis: effects on macular morphology and function.
    Testa F; Di Iorio V; Gallo B; Marchese M; Nesti A; De Rosa G; Melillo P; Simonelli F
    Ophthalmic Genet; 2019 Jun; 40(3):207-212. PubMed ID: 31149861
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of dorzolamide for patients with X-linked retinoschisis.
    Apushkin MA; Fishman GA
    Retina; 2006 Sep; 26(7):741-5. PubMed ID: 16963845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STRUCTURAL AND FUNCTIONAL MONITORING OF EXTRAMACULAR CYSTOID SPACES IN A CASE OF X-LINKED RETINOSCHISIS TREATED WITH ACETAZOLAMIDE.
    Collison FT; Fishman GA
    Retin Cases Brief Rep; 2018 Fall; 12(4):318-321. PubMed ID: 27984356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical brinzolamide for foveal schisis in juvenile retinoschisis.
    Yang FP; Willyasti K; Leo SW
    J AAPOS; 2013 Apr; 17(2):225-7. PubMed ID: 23541677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetazolamide in retinoschisis: a prospective study.
    Gurbaxani A; Wei M; Succar T; McCluskey PJ; Jamieson RV; Grigg JR
    Ophthalmology; 2014 Mar; 121(3):802-3.e3. PubMed ID: 24309554
    [No Abstract]   [Full Text] [Related]  

  • 11. Paradoxical Anatomic Response to Topical Carbonic Anhydrase Inhibitor in X-linked Retinoschisis.
    Menke B; Walters A; Payne JF
    Ophthalmic Surg Lasers Imaging Retina; 2018 Feb; 49(2):142-144. PubMed ID: 29443366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-linked Juvenile Retinoschisis in a Young Female.
    Ranabhat S; Byanju R; Khadka S
    J Nepal Health Res Counc; 2022 Jun; 20(1):260-264. PubMed ID: 35945887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of carbonic anhydrase inhibitors in the retreatment of cystic macular lesions in retinitis pigmentosa and X-linked retinoschisis.
    Thobani A; Fishman GA
    Retina; 2011 Feb; 31(2):312-5. PubMed ID: 20966823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. USE OF A CARBONIC ANHYDRASE INHIBITOR IN X-LINKED RETINOSCHISIS: Effect on Cystic-Appearing Macular Lesions and Visual Acuity.
    Andreuzzi P; Fishman GA; Anderson RJ
    Retina; 2017 Aug; 37(8):1555-1561. PubMed ID: 27828908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TOPICAL CARBONIC ANHYDRASE INHIBITORS IN THE LONG-TERM TREATMENT OF JUVENILE X-LINKED RETINOSCHISIS.
    Schmitt MA; Wang K; DeBenedictis MJ; Traboulsi EI
    Retina; 2022 Nov; 42(11):2176-2183. PubMed ID: 35982512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macular cysts in retinal dystrophy.
    Ganesh A; Stroh E; Manayath GJ; Al-Zuhaibi S; Levin AV
    Curr Opin Ophthalmol; 2011 Sep; 22(5):332-9. PubMed ID: 21730849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dramatic regression of macular and peripheral retinoschisis with dorzolamide 2 % in X-linked retinoschisis: a case report.
    Sadaka A; Sisk RA
    J Med Case Rep; 2016 Jun; 10(1):142. PubMed ID: 27246168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolution of mid-peripheral schisis in x-linked retinoschisis with the use of dorzolamide.
    Collison FT; Genead MA; Fishman GA; Stone EM
    Ophthalmic Genet; 2014 Jun; 35(2):125-7. PubMed ID: 23514609
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo imaging reveals novel aspects of retinal disease progression in Rs1h(-/Y) mice but no therapeutic effect of carbonic anhydrase inhibition.
    Zhour A; Bolz S; Grimm C; Willmann G; Schatz A; Weber BH; Zrenner E; Fischer MD
    Vet Ophthalmol; 2012 Sep; 15 Suppl 2():123-33. PubMed ID: 22672048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of optical coherence tomography findings with visual acuity and macular lesions in patients with X-linked retinoschisis.
    Apushkin MA; Fishman GA; Janowicz MJ
    Ophthalmology; 2005 Mar; 112(3):495-501. PubMed ID: 15745780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.